patient preference methods
preference studies
patient-preference elicitation studies
patient organisations
patient organizations
existing methods
new methods
well-known methods
suitable methods
Patient Preferences
evaluation of preference elicitation methods
preference study
project recommendations
reimbursement agencies
availability of large patient cohorts
large number of case studies
use of simulation studies
entire drug life cycle
smarter design of case studies
HTA bodies
medicinal product life cycle
broad representation of stakeholders
decisions
project management
medical needs
decision making
industry partners
relevant stakeholders
broad array
key decision points
regulatory authorities
patients
academia
SME members
benefit risk assessments
randomized manner
value
deviations
overview
combinations
clinical testing
early stages
sensitivity of outcomes
withdrawal of drugs
newer ones
discussions
contributions
market
consortium
practices